跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AT-282
首页
药物
AT-282
AT-282
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Composition comprising one or more flavonoids, method of obtaining such composition and use thereof as UV-absorbing agent
申请人: FLAVONE SUNPRODUCTS AS
优先权: 1997
US
SYNTHETIC MYOSTATIN PEPTIDE ANTAGONISTS
申请人: BOWER ROBERT SYNDECOMBE
优先权: 2010
CN
US
2 件公开
CUCUMBER MOSAIC VIRUS ATTENUATED STRAIN
申请人: KYOTO BIKEN LABORATORIES INC
优先权: 2018
CN
Method of detecting risk factor for the onset of arteriosclerosis
申请人: NAGANO MAKOTO
优先权: 2000
US
COMPLEMENT COMPONENT IRNA COMPOSITIONS AND METHODS OF USE THEREOF
申请人: ALNYLAM PHARMACEUTICALS INC
优先权: 2013
EP
2 件公开
BISPECIFIC ANTIBODY TARGETING EGFR AND AXL, DRUG CONJUGATE THEREOF, AND USE THEREOF
申请人: BEIJING BIOSTARGEN BIOTECHNOLOGY CO LTD
优先权: 2024
WO
MODULATION OF IN VIVO CARDIAC PERFORMANCE USING HYPER PHOSPHOMIMETIC CMYBP-C
申请人: UNIV CASE WESTERN RESERVE
优先权: 2024
WO
一种靶向PTGS1蛋白稳定新抗原表位的单克隆抗体及其应用
申请人: 唐山市妇幼保健院
优先权: 2025
CN
药物
反馈